Clinical trial · no report yet · Phase 2
EDEN
De-escalation Study for Stage IIa/IIb < 3 cm Seminoma
- NCT05529251 ↗
- Recruiting
- Centre Leon Berard
- Focused
We haven't built a report for this trial yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Preliminary discovery
Commentary in our index that names this trial so far
Podcasts, YouTube videos and X posts we have indexed. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build.
| Channel | Found | |
|---|---|---|
| Podcasts | 2 | |
| X threads | 1 |
The trial
ClinicalTrials.gov- Official title
- Prospective Therapeutic De-escalation and miRNA-M371 Biomarker Evaluation Phase II Study for Stage IIa/IIb < 3 cm Seminomas
- Phase
- Phase 2
- Status
- Recruiting
- Conditions
- Seminoma; Stage II
- Interventions
- Radiotherapy boost; Carboplatin AUC7; 3 cycles of EP
- Arms
- ARM A · Experimental
- ARM B · Experimental
- ARM C · Other
- OBSERVATIONAL COHORT · No intervention
- Enrollment
- 90 (estimated)
- Primary outcomes
- PFR-36M
- Sponsor
- Centre Leon Berard
- Start
- Sep 6, 2022
- Primary completion
- May 4, 2032 (estimated)
- Results posted
- No
- Registry record
- NCT05529251 · updated Sep 15, 2026